Ozempic alternative: cheaper options that actually work (2026)

Ozempic costs $900–$1,200 per month without insurance [1]. It’s also FDA-approved for type 2 diabetes, not weight loss (that’s Wegovy). So if you’re looking for weight loss medication, you’re already using it off-label, paying premium prices for a drug that wasn’t designed for your goal.

There are real alternatives. Some use the exact same active ingredient for a fraction of the cost. Others work through different mechanisms entirely. Here’s what’s actually available in 2026, with honest data on each.

Quick comparison table

Alternative	Type	Avg. weight loss	Monthly cost	Rx required?
Compounded semaglutide	GLP-1 agonist (same as Ozempic)	~14.9% at 68 weeks	$179–$299	Yes
Tirzepatide (Mounjaro/Zepbound)	Dual GLP-1/GIP agonist	~20.9% at 72 weeks	$1,000–$1,200 (brand)	Yes
Compounded tirzepatide	Dual GLP-1/GIP agonist	Same as brand	$299–$499	Yes
Phentermine (Adipex-P)	Sympathomimetic amine	~5–10% over 12 weeks	$30–$75	Yes
Contrave (naltrexone/bupropion)	Opioid antagonist + antidepressant	~5–6% at 56 weeks	$99–$400	Yes
Lifestyle changes alone	Diet + exercise	~3–5% at 12 months	$0	No

Compounded semaglutide: same molecule, 80% cheaper

This is the most direct Ozempic alternative because it is Ozempic’s active ingredient. Compounded semaglutide is the same molecule (semaglutide) prepared by licensed 503A or 503B compounding pharmacies instead of Novo Nordisk.

The evidence

The data behind semaglutide comes from Novo Nordisk’s STEP trial program. STEP 1 enrolled 1,961 adults with obesity and found that semaglutide 2.4mg weekly produced a mean weight loss of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. That’s roughly 34 pounds for someone starting at 230 lbs.

Whether the semaglutide molecule comes from Novo Nordisk’s manufacturing plant or a licensed compounding pharmacy, it interacts with GLP-1 receptors the same way. A 2024 study in Pharmaceutical Research examined compounded semaglutide products and found that quality-controlled compounded formulations maintained comparable pharmaceutical properties [3].

Cost and access

Compounded semaglutide typically costs $179–$299/month through telehealth providers, including the medical consultation. Compare that to Ozempic’s $900–$1,200 retail price or even Wegovy’s $1,349 list price [1].

At PURE Peptide Clinic, compounded semaglutide programs include prescriber consultations, dosing adjustments, and medication from a licensed 503B pharmacy. It’s the same weekly injection protocol.

Who it’s best for

Anyone who responds well to semaglutide but can’t afford brand pricing. If you’ve tried Ozempic samples from your doctor and liked the results, compounded semaglutide gives you the same experience at a sustainable cost.

For more on safety and sourcing, read our guide on whether compounded semaglutide is safe and the differences between 503A and 503B pharmacies.

Tirzepatide (Mounjaro / Zepbound)

Tirzepatide is arguably the strongest Ozempic alternative from a pure effectiveness standpoint. It’s a dual GLP-1/GIP receptor agonist, meaning it activates two gut hormone pathways instead of one.

The evidence

The SURMOUNT-1 trial (2,539 participants, 72 weeks) showed tirzepatide at the highest dose (15mg) produced an average weight loss of 20.9% of body weight [4]. At the 10mg dose, it was 19.5%. At 5mg, 15.0%. All doses outperformed semaglutide’s 14.9% from the STEP 1 trial, though these were separate studies with different populations.

The SURMOUNT-2 trial confirmed these results specifically in people with type 2 diabetes, showing 12.8% weight loss at the 10mg dose and 14.7% at 15mg [5].

Cost

Brand tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) runs $1,000–$1,200/month without insurance. That’s comparable to Ozempic.

Compounded tirzepatide is available through some telehealth providers at $299–$499/month. Availability depends on current FDA shortage designations and compounding regulations.

For a detailed head-to-head breakdown, see our semaglutide vs tirzepatide comparison.

Who it’s best for

People who want maximum weight loss and can afford the higher price point, or those who didn’t get adequate results from semaglutide. The additional GIP receptor activation may provide benefits that semaglutide alone doesn’t.

Phentermine

Phentermine is the oldest prescription weight loss drug still in widespread use. It’s been around since 1959 and remains one of the most commonly prescribed options, largely because it’s cheap.

The evidence

Phentermine works as a sympathomimetic amine that stimulates your nervous system to suppress appetite. Clinical data shows typical weight loss of 5–10% of body weight over 12 weeks [6]. That’s roughly a third of what semaglutide achieves, and phentermine is only approved for short-term use (up to 12 weeks).

The phentermine/topiramate combination (Qsymia) produces better results. A study in Diabetes Care found the combination produced 6.7–8.9% weight loss over 56 weeks in patients with type 2 diabetes [7].

Cost

Generic phentermine costs $30–$75/month. That’s by far the cheapest prescription option. Qsymia (the combination) runs $150–$200/month without insurance.

The downsides

Phentermine raises heart rate and blood pressure. It’s classified as a Schedule IV controlled substance due to potential for dependence. You can’t take it long-term, which means weight regain after stopping is common. It’s also contraindicated if you have cardiovascular disease, hyperthyroidism, or a history of substance abuse.

Who it’s best for

People looking for a short-term jumpstart on a tight budget. It’s not a long-term solution, but some prescribers use it as a bridge while patients establish diet and exercise habits. It doesn’t compare to GLP-1 medications for sustained weight management.

Contrave (naltrexone/bupropion)

Contrave combines naltrexone (an opioid antagonist) with bupropion (an antidepressant) to target food cravings through a different pathway than GLP-1 drugs.

The evidence

The COR-I trial (1,742 participants, 56 weeks) found that naltrexone/bupropion produced a mean weight loss of 5.0–6.1% of body weight compared to 1.3% with placebo [8]. That’s about a third of what semaglutide delivers, but it works through entirely different brain pathways.

The combination targets the hypothalamus and mesolimbic dopamine circuits, which may help specifically with emotional eating and food-reward cravings rather than just appetite suppression.

Cost

Brand Contrave costs $300–$400/month without insurance. Some telehealth providers offer generic naltrexone/bupropion for $99–$150/month.

The downsides

Common side effects include nausea (33%), constipation (19%), headache (18%), and insomnia. There’s a black box warning about suicidal thoughts associated with bupropion, particularly in younger adults. It can’t be used with opioid medications.

Who it’s best for

People whose weight issues are primarily driven by emotional eating or food cravings, particularly if they also deal with depression (bupropion has antidepressant properties). It’s not the right pick if you’re looking for maximum weight loss numbers.

Lifestyle changes

Let’s be honest about this one. Diet and exercise alone produce average weight loss of 3–5% of body weight at 12 months in clinical settings [9]. That’s real but modest.

The reason medications like semaglutide exist is that sustained weight loss through lifestyle changes alone has a high failure rate. A meta-analysis of behavioral weight loss interventions found that most participants regain 30–50% of lost weight within the first year after treatment ends [9].

That said, lifestyle changes amplify whatever medication you’re using. The STEP 1 trial included lifestyle intervention for all participants, including the semaglutide group [2]. Medication and behavior changes aren’t competing approaches. They’re complementary.

What actually works

The interventions with the best evidence are caloric deficit diets (any structure: Mediterranean, low-carb, portion control), resistance training (preserves muscle mass during weight loss), and consistent physical activity (150+ minutes/week of moderate exercise) [9].

For people with PCOS, insulin resistance, or other metabolic conditions, medication often makes the difference between marginal and meaningful results. See our guide on PCOS weight loss medication for specific options.

How to choose the right alternative

The decision comes down to three factors: how much weight you need to lose, what you can afford, and what your medical history allows.

If you need significant weight loss (30+ lbs) and can afford $179–$299/month: Compounded semaglutide is the sweet spot. Same active ingredient as Ozempic, proven clinical data, sustainable pricing. Check if you qualify.

If you want maximum weight loss and budget isn’t the primary concern: Tirzepatide (brand or compounded) has the strongest clinical data, with an edge of 5–6 percentage points over semaglutide in weight loss.

If you need something temporary and cheap: Phentermine at $30–$75/month works for a short-term boost, but plan for what comes after.

If emotional eating is the main issue: Contrave targets food-reward pathways specifically, though overall weight loss is more modest.

If medication isn’t an option: Structured lifestyle changes with professional support (dietitian, exercise program) produce real but smaller results. They also make every other option on this list work better.

FAQ

What is the closest over-the-counter alternative to Ozempic?▼

There is no OTC equivalent to Ozempic. Semaglutide requires a prescription. Some supplements claim GLP-1-like effects, but none have clinical data comparable to actual GLP-1 medications. The most affordable prescription alternative is compounded semaglutide at $179–$299/month. For more on what’s available without a prescription, see our over-the-counter peptides guide.

Is compounded semaglutide the same as Ozempic?▼

The active ingredient is the same: semaglutide. What differs is the manufacturer (a licensed compounding pharmacy instead of Novo Nordisk), the delivery format (typically a vial and syringe rather than a pre-filled pen), and the price (roughly 75–85% less). The molecule interacts with your GLP-1 receptors identically. Read our full breakdown on compounded semaglutide safety.

Why is Ozempic used off-label for weight loss?▼

Ozempic is FDA-approved for type 2 diabetes. Wegovy, which contains the same active ingredient at a higher dose (2.4mg vs 0.5–2mg), is approved for weight loss. Doctors prescribe Ozempic off-label for weight management because semaglutide’s weight loss effects are well-established from the STEP trials [2]. It’s common but means insurance is less likely to cover it.

Can I switch from Ozempic to a cheaper alternative?▼

Yes. If switching to compounded semaglutide, the transition is straightforward since the active ingredient is the same. Your prescriber will match your current dose. Switching to a different drug class (tirzepatide, phentermine, Contrave) requires medical supervision to manage the transition and adjust dosing.

Which Ozempic alternative causes the fewest side effects?▼

All GLP-1 medications (semaglutide, tirzepatide) have similar GI side effects: nausea, diarrhea, vomiting. These are typically worst during dose titration and improve over weeks. Phentermine causes different side effects (elevated heart rate, insomnia, dry mouth). Contrave’s main issues are nausea and headache. There’s no option with zero side effects. For detailed side effect comparisons, see our Ozempic face guide and muscle loss prevention guide.

How much weight can I lose with an Ozempic alternative?▼

Based on clinical trial data: compounded semaglutide produces the same ~14.9% weight loss as brand semaglutide [2]. Tirzepatide averages 15–20.9% depending on dose [4]. Phentermine produces 5–10% over a shorter period [6]. Contrave produces 5–6% over 56 weeks [8]. Lifestyle changes alone average 3–5%.

Is it safe to buy compounded semaglutide online?▼

It’s safe when purchased through a legitimate telehealth provider that uses licensed 503A or 503B compounding pharmacies. Avoid “research chemical” sellers or sources outside the regulated pharmacy system. A licensed prescriber should evaluate you before any prescription. See our guide on buying semaglutide online for what to look for.

Will there ever be a generic Ozempic?▼

Not soon. Novo Nordisk’s patents on semaglutide extend for several more years. When generics do arrive, they’ll need to go through the FDA’s biosimilar approval pathway, which takes additional time. Compounded semaglutide is the closest thing to an affordable alternative currently available. For more on this topic, see our generic Ozempic guide.

The bottom line

Ozempic works. The clinical data is clear. But paying $900–$1,200/month for an off-label prescription when the same molecule is available from licensed pharmacies at $179–$299/month doesn’t make financial sense for most people.

Compounded semaglutide gives you the same active ingredient, the same mechanism of action, and comparable results at a fraction of the brand cost. If you want to see whether you’re a candidate, start your evaluation here.

References

1. GoodRx. How much Ozempic costs without insurance and 9 ways to save. Updated January 2026. https://www.goodrx.com/ozempic/how-to-save-on-ozempic
2. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
3. Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide Drugs. Pharm Res. 2024. https://pubmed.ncbi.nlm.nih.gov/39379664/
4. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(4):327-340. https://pubmed.ncbi.nlm.nih.gov/35658024/
5. Garvey WT, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. https://pubmed.ncbi.nlm.nih.gov/37385275/
6. Aronne LJ, et al. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care. 2014;37(12):3309-3316. https://pubmed.ncbi.nlm.nih.gov/25249652/
7. Aronne LJ, et al. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care. 2014;37(12):3309-3316. https://pubmed.ncbi.nlm.nih.gov/25249652/
8. Greenway FL, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I). Lancet. 2010;376(9741):595-605. https://pubmed.ncbi.nlm.nih.gov/20673995/
9. Hall KD, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin North Am. 2018;102(1):183-197.
10. Navigating compounded semaglutide: what health care providers need to know. Am J Manag Care. 2025. https://pubmed.ncbi.nlm.nih.gov/40966636/